Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Glyburide/Metformin 5 mg/500 mg Tablets
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00836472
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 52
- Registration Number
- NCT00835705
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Finasteride 5 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835666
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Sertraline Hydrochloride 100 mg Tablets, Fed
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 18
- Registration Number
- NCT00836667
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Finasteride 5 mg Tablets, Non-fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 20
- Registration Number
- NCT00835796
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00836056
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Cefdinir Capsules 300 mg, Fasting
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835484
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Cefprozil for Oral Suspension 250 mg/5 mL, Fasting
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT00835614
- Locations
- 🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States
🇺🇸Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DURICEF® capsules 500 mg
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT00835081
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Famciclovir 500 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00834431
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇨🇦Ba Research Co., Toronto, Ontario, Canada